Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Revenue Revenue Growth	373.49	368.83	278.44	230.87	195.25	153.79
Revenue Growth	26.63%	32.46%	20.61%	18.24%	26.96%	24.51%
Gross Profit Gross Profit Growth	295.6	293.22	220.81	189.29	163.99	126.5
Operating Income Operating Income Growth	113.54	116.47	78.97	44.2	25.74	27.01
Net Income Net Income Growth	109.68	113.13	78.85	40.88	35.89	44.71
Earnings Per Share EPS Growth	1.64	1.69	1.20	0.62	0.54	0.79
EPS Growth	23.38%	40.83%	93.55%	14.82%	-31.65%	5.33%

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Implanted Medical Devices Implanted Medical Devices Growth	356	271.5	224.59	189.45	147.6
Others Others Growth	12.83	6.95	6.28	5.8	6.18
Total Total Growth	368.83	278.44	230.87	195.25	153.79

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Investments Cash & Investments Growth	301.24	305.83	249.78	219.5	192.02	385.92
Total Debt Total Debt Growth	8.81	-	1.01	53.13	81.65	110.7
Net Cash (Debt) Net Cash Growth	292.43	305.83	248.77	166.36	110.37	275.22
Net Cash Growth	25.10%	22.94%	49.53%	50.73%	-59.90%	61.87%
Net Cash Per Share Net Cash Per Share Growth	4.37	4.57	3.79	2.52	1.66	4.86

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Cash Flow Operating Cash Flow Growth	113.86	139.87	116.38	107.69	48.31	66.51
Capital Expenditures CapEx Growth	-27.23	-23.82	-33.16	-40.09	-135.96	-152.71
Free Cash Flow Free Cash Flow Growth	86.63	116.05	83.22	67.6	-87.65	-86.2
Free Cash Flow Growth	-15.39%	39.44%	23.11%	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Gross Margin	79.14%	79.50%	79.30%	81.99%	83.99%	82.25%
Operating Margin	30.40%	31.58%	28.36%	19.15%	13.18%	17.56%
Pretax Margin	32.56%	34.21%	33.46%	20.80%	20.47%	33.55%
Profit Margin	29.37%	30.67%	28.32%	17.71%	18.38%	29.08%
FCF Margin	23.20%	31.46%	29.89%	29.28%	-44.89%	-56.05%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Dividend Per Share Dividend Per Share Growth	0.700	0.700	0.600	0.400	0.200	0.100
Dividend Per Share Growth	16.67%	16.67%	50.00%	100.00%	100.00%	-
Dividend Yield	1.17%	1.05%	1.46%	0.95%	0.56%	0.17%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	34.81	39.80	35.28	70.37	67.88	90.30
Forward PE	-	46.68	40.83	46.57	-	-
P/FCF Ratio	43.96	38.80	33.43	42.55	-	-
PS Ratio	10.20	12.21	9.99	12.46	12.48	26.26

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error